EFFECTIVENESS OF THE ANESTHETIC AQUI-S® 20E IN MARINE FINFISH AND ELASMOBRANCHS
Abstract Immersion anesthetics are used in hatchery settings by veterinarians, field biologists, and laboratory researchers to aid in handling finfish for medical procedures, research purposes, and moderating perceived stress responses. The only Food and Drug Administration– (FDA) approved anesthetic for food fish, tricaine methanesulfonate, requires a 21-d withdrawal period prior to harvest. Ten percent eugenol (AQUI-S® 20E) has been gaining momentum for FDA approval because of its 0-d withdrawal time if fish are not of harvestable size within 72 h of exposure. We performed two trials to determine appropriate anesthetic doses for two cultured marine finfish: Atractoscion nobilis (white seabass, WSB) and Seriola lalandi (California yellowtail, YT). Fish were held in a treated water bath for 10 min or until opercular beat rate slowed to a rate of <2 beats/min. Based on these results, we conducted a field trial with wild Paralabrax maculatofasciatus (spotted bay bass), Paralabrax nebulifer (barred sand bass), Paralichthys californicus (California halibut), Triakis semifasciata (leopard shark), and Mustelus californicus (grey smooth-hound) at a single dosing regime, with animals held 5–10 min in anesthetic baths. Anesthetic dosing of 35–55 mg L−1 provided relatively fast induction and good anesthetic maintenance in cultured and wild finfish. Anesthetic induction times were comparable among S. lalandi and A. nobilis at 35–mg L−1 to 75–mg L−1 doses, but recovery times were variable. Mortality rates of 20-90% were observed at higher doses (75 mg L−1 and 100 mg L−1, A. nobilis; 55 mg L−1 and 75 mg L−1, S. lalandi). The apparent increase in sensitivity of S. lalandi may have been associated with nutritional stress in the fish tested. There were no differences in time to anesthesia or recovery among wild finfish species tested at a single dose. Anesthetic induction, maintenance, and recovery were less predictable in the elasmobranch species tested and additional trials are needed to determine optimal dosing.
Sharks, rays and abortion: The prevalence of capture-induced parturition in elasmobranchs
The direct impacts of fishing on chondrichthyans (sharks, rays and chimeras) are well established. Here we review a largely unreported, often misinterpreted and poorly understood indirect impact of fishing on these animals — capture-induced parturition (either premature birth or abortion). Although direct mortality of discarded sharks and rays has been estimated, the prevalence of abortion/premature birth and subsequent generational mortality remains largely unstudied. We synthesize a diffuse body of literature to reveal that a conservative estimate of > 12% of live bearing elasmobranchs (n = 88 species) show capture-induced parturition. For those species with adequate data, we estimate capture-induced parturition events ranging from 2 to 85% of pregnant females (average 24%). To date, capture-induced parturition has only been observed in live-bearing species. We compile data on threat-levels, method of capture, reproductive mode and gestation extent of premature/aborted embryos. We also utilise social media to identify 41 social-media links depicting a capture-induced parturition event which provide supplementary visual evidence for the phenomenon. The mortality of embryos will have implications for elasmobranch populations, and there are limited options to deal with this problem. This review is the first to synthesize available data on capture-induced parturition in sharks and rays, and highlights an important ethical and management issue for fishers and managers deserving of much greater attention.
New insights in developmental origins of different GnRH (gonadotrophin-releasing hormone) systems in perciform fish: an immunohistochemical study in the European sea bass (Dicentrarchus labrax)
The knowledge of the roles and origins of different gonadotrophin-releasing hormone (GnRH) systems could greatly contribute to improve the understanding of mechanisms involved in the physiological control of early development, puberty and spawning. Thus, in this study, we have analyzed the distribution of the cells expressing salmon GnRH, seabream GnRH and chicken GnRH-II forms in the brain and pituitary of developing sea bass using specific antibodies to their corresponding GnRH-associated peptides. The first prepro-chicken GnRH-II-immunoreactive cells arose in the germinal zone of the third ventricle at 4 days after hatching, increasing their number from days 10 to 30, in which they adopted their adult position. The prepro-chicken GnRH-II-immunoreactive fibers became conspicuous in the first week and from day 26 they reached almost all brain areas, especially the hindbrain, being never detected in the pituitary. First prepro-salmon GnRH-immunoreactive cells were detected in the olfactory placode at day 7 after hatching and reached the olfactory bulbs at day 10. Migrating prepro-salmon GnRH cells arrived at the ventral telencephalon at day 15, and became apparent in the preoptic area from day 45. The prepro-salmon GnRH innervation was more evident in the forebrain and increased notably between 10 and 30 days, at which fibers already extended from the olfactory bulbs to the medulla. A few prepro-salmon GnRH-immunoreactive fibers were observed in the pituitary from day 30. The prepro-seabream GnRH-immunoreactive cells were first detected at day 26 in the rostral olfactory bulbs. On day 30, prepro-seabream GnRH-immunoreactive cells were also present in the ventral telencephalon, reaching the preoptic area and the hypothalamus at 45 and 60 days, respectively. The prepro-seabream GnRH innervation appeared restricted to the ventral forebrain, increasing notably during the sixth week, when fibers also reached the pituitary. A significant prepro-seabream GnRH innervation was not detected in the pituitary until day 60.